“scholar-rock” Archives

in
Entry Author Date Location
Bio Roundup: Moderna Publishes, Life Science Cash, AdComm Votes & More 07/17/20 National
Novartis Leads $100M Round for Fibrosis-Focused Pliant Therapeutics 03/03/20 San Francisco
miRagen Restructures to Focus on Fibrosis, Inks $20M Stock Deal 12/12/19 Boulder/Denver
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More 08/30/19 National
Goldfinch Bio Lands $55M From Gilead in Kidney Drug R&D Pact 05/08/19 Boston
Bio-JPM Roundup: Lilly Buys Loxo, Sage’s Stock Soars, ALS Cash & More 01/07/19 National
Gilead, Scholar Rock Sign $80M Up Front Deal for Fibrosis Drugs 12/19/18 Boston
CAMP4 Hauls in $30M to Map New Ground with Drug Discovery Tech 05/31/18 Boston
Bio Roundup: Brii Does China, Hemophilia Updates, Right to Try & More 05/25/18 National
Biotech IPOs Roll On as Kiniksa, Scholar Rock Get $227M Combined 05/24/18 Boston
Bio Roundup: IDO Fallout, Express Scripts Dumps Amgen, Isaly Out & More 05/04/18 National
Kentucky Biotech CEO’s Message For McConnell: I’ll Be Muslim, Too 02/07/17 National
East Coast Bio Roundup: NY Startups, Editas, Bonney, C4 & (Much) More 01/08/16 Boston
Scholar Rock Rolls Up $36M To Move Muscle Drug To Clinical Trials 01/04/16 Boston
Scholar Rock Lands $36,000,000 Series B Financing Round 01/04/16 Boston
Scholar Rock’s Local Approach to Immune Disease Nabs $20M 09/15/14 Boston
Scholar Rock Garners $20,000,000 Series A Financing 09/15/14 Boston
Xconomy Boston’s Top Stories of Q1 2014: Editor’s Picks 03/31/14 Boston
East Coast Biotech Roundup: Gerngross, Akili, Intercept, & More 01/10/14 Boston
East Coast Biotech Roundup: Scholar Rock, Dicerna, Eleven, & More 01/03/14 Boston
Scholar Rock Aims to Hit Disease-Causing Proteins in a “Niche” 01/02/14 Boston
Page 1 of 1